⭐ Start off 2025 with a powerful boost to your portfolio: January’s freshest AI-picked sharesUnlock shares

Laser Photonics reports strong start after CMS acquisition

Published 17/12/2024, 12:14
LASE
-

ORLANDO, Fla. - Laser Photonics Corporation (NASDAQ: LASE), a global developer of industrial laser systems with a market capitalization of $77.6 million, has announced substantial early returns following its recent acquisition of Control Micro Systems, Inc. (CMS). The acquisition, which closed for $1.05 million, has led to nearly $600,000 in cash flow from accounts receivable collections and nearly $600,000 in new orders from CMS in just over a month. According to InvestingPro data, LASE maintains a strong liquidity position with a current ratio of 5.38, indicating robust financial flexibility for such strategic acquisitions.

CMS, which specializes in precision laser systems for pharmaceutical applications, has bolstered Laser Photonics' business by diversifying into recession-resistant markets and enhancing its engineering capabilities. The early financial results have been promising, with a revenue backlog exceeding $3.7 million, signaling potential for long-term contributions to revenue and profit. InvestingPro analysis reveals impressive gross profit margins of 55.33%, suggesting strong pricing power in its markets. Analysts anticipate sales growth of 3.82% for fiscal year 2024.

The CMS acquisition is particularly strategic as it allows Laser Photonics to tap into the growing pharmaceutical market, where CMS's laser drilling systems are used in controlled-release pharmaceutical production. These systems are crucial for manufacturers to control drug release rates. With the controlled-release pharmaceuticals market projected to grow at a CAGR of nearly 11% through 2030, CMS is poised for growth under Laser Photonics' leadership.

Wayne Tupuola, CEO of Laser Photonics, expressed optimism about expanding CMS's presence in the pharmaceutical market. He highlighted the synergy between CMS's innovative technologies and Laser Photonics' sales and marketing infrastructure as a pathway to scale CMS solutions and penetrate deeper into the pharmaceutical sector.

In addition to pharmaceuticals, CMS's expertise in custom laser solutions for various industrial applications is expected to enhance Laser Photonics' product offerings. By integrating CMS's custom laser capabilities, Laser Photonics aims to develop tailored systems for diverse industries, potentially creating cross-selling opportunities and fostering product development synergies.

Laser Photonics is known for its industrial laser systems used in applications such as surface cleaning, rust removal, and de-painting, targeting traditional sand and abrasives blasting markets. The company serves clients across aerospace, automotive, defense, energy, maritime, nuclear, and space industries.

This press release includes forward-looking statements, which are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially. Laser Photonics has made no further comments on the future expectations beyond what was stated in the press release. This report is based on a press release statement and aims to present the facts without bias or promotional language. For deeper insights into LASE's financial health and valuation metrics, investors can access comprehensive analysis through InvestingPro, which offers exclusive access to 13+ additional ProTips and detailed financial metrics for informed decision-making.

In other recent news, Laser Photonics reported a third-quarter loss per share of $0.13, a wider loss compared to the same period last year. The company's revenue for the quarter was $800,000, marking a 22% year-over-year decline but a 21% sequential increase from the previous quarter. Despite the financial setbacks, Laser Photonics highlighted strategic acquisitions and ongoing innovations as key factors in its future growth strategy. The company's gross margin improved by 11.40 basis points to 85.8%. Furthermore, Laser Photonics recently acquired Controlled Microsystems to enhance its product offerings and expand into healthcare and renewable energy markets.

The company's performance in the third quarter showed a notable decrease in revenue compared to the previous year, yet a sequential improvement from the second quarter. Laser Photonics is navigating a challenging market environment, with a strategic emphasis on expanding its product portfolio and market reach. The acquisition of Controlled Microsystems is expected to bolster its capabilities in industrial laser markets.

CEO Wayne Topolla emphasized the company's commitment to innovation, stating, "We remain committed to innovating in our core industrial laser markets." He also highlighted the anticipated growth in the pharmaceutical market, which is expected to expand at nearly 11% annually through 2030, as a key opportunity for the company.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.